Sanofi stock gains as analysts lift 2026 estimates
Published on 09/03/2026 at 07:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Sanofi (FR0000127771) stock is trading with a market cap of USD 105.293 billion and a closing price of USD 44.47 on September 2, 2026, while 2026 analyst estimates point to EPS of 4.99 USD and revenue of 12.3 billion USD.
The latest visible analyst snapshot from Yahoo Finance also shows 2027 estimates of EPS 5.38 USD and revenue 12.3 billion USD, with current-year EPS at 4.99 USD, which frames the stock around a modest earnings step-up into next year.
Estimates set the tone
Sanofi shares finished at USD 44.47 on September 2, 2026, and the same quote page shows a year-to-date move of 0.23 percent at the latest visible intraday update. The market capitalization is USD 105.293 billion, which keeps the group among the largest global drugmakers.
Analyst consensus in the same snapshot lists 2 analysts for the current quarter, 5 for the current year and 5 for the next year. The average estimate for 2026 EPS is 4.99 USD, compared with 4.67 USD in the year-ago column, a difference of 0.32 USD.
EPS outlook stays constructive
The quoted estimate table shows quarterly EPS actuals of 1.69 USD, 0.91 USD, 1.10 USD and 1.20 USD for the four most recent quarters ending June 30, 2026, alongside surprise percentages of 8.14 percent, 7.38 percent, 7.26 percent and 5.59 percent.
That pattern matters because it links Sanofi's current valuation to a run of beats rather than a single quarter. For investors, the combination of 4.99 USD expected EPS in 2026 and 5.38 USD in 2027 is the clearest near-term reference point.
What the business sells
Sanofi's product mix is still anchored by prescription medicines and vaccines, and the earnings table now places more weight on the companys ability to convert that portfolio into higher per-share profit. The current estimate gap of 0.39 USD between 2026 EPS and 2027 EPS gives the stock a simple test: whether earnings keep rising into next year.
The same snapshot also shows revenue expectations of 12.3 billion USD for both the current quarter and the current year view, which means the market is watching margin, not only top-line growth.
Stock level to watch
Sanofi stock closed at USD 44.47 on September 2, 2026, with a market capitalization of USD 105.293 billion on the same quote page. That leaves the shares tied closely to the next reported estimate move rather than to a fresh price shock.
Sanofi at a glance
- Company: Sanofi
- ISIN: FR0000127771
- Ticker: SNY
- Trading venue: NasdaqGS
- Price (as of September 2, 2026): USD 44.47
- Market capitalization: USD 105.293 billion (as of September 2, 2026)
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: CAC 40
